-
公开(公告)号:EP4047001A2
公开(公告)日:2022-08-24
申请号:EP21218204.2
申请日:2017-07-05
申请人: The Broad Institute, Inc. , Dana-Farber Cancer Institute, Inc. , The General Hospital Corporation
发明人: GRAY, Nathanael S. , LIANG, Yanke , CHOI, Hwan Geun , SUNDBERG, Thomas , SHAMJI, Alykhan , XAVIER, Ramnik , FISHER, David E. , MUJAHID, Nisma
IPC分类号: C07D487/04 , A61K31/519 , A61P35/00 , A61P7/00 , A61P19/00 , A61P21/00 , A61P25/00 , A61P37/00
摘要: The present disclosure provides compounds of Formula ( I ), ( II ), and ( III ). The provided compounds are able to bind protein kinases ( e . g ., SIK) and may be useful in modulating ( e.g., inhibiting) the activity of a protein kinase ( e.g., SIK, ( e.g., SIK1, SIK2, or SIK3)) in a subject or cell. The provided compounds may be useful in treating or preventing a disease ( e . g ., proliferative disease, musculoskeletal disease, genetic disease, hematological disease, neurological disease, painful condition, psychiatric disorder, or metabolic disorder) in a subject in need thereof. Also provided are pharmaceutical compositions, kits, methods, and uses that include or involve a compound described herein.
-
公开(公告)号:EP4121046A1
公开(公告)日:2023-01-25
申请号:EP21771391.6
申请日:2021-03-17
发明人: FERGUSON, Fleur M. , GRAY, Nathanael S. , HAGGARTY, Stephen J. , TELO BAPTISTA LIMA DA SILVA, Maria Catarina
IPC分类号: A61K31/4166 , A61K31/495 , A61K31/381
-
公开(公告)号:EP4047001A3
公开(公告)日:2022-11-30
申请号:EP21218204.2
申请日:2017-07-05
申请人: The Broad Institute, Inc. , Dana-Farber Cancer Institute, Inc. , The General Hospital Corporation
发明人: GRAY, Nathanael S. , LIANG, Yanke , CHOI, Hwan Geun , SUNDBERG, Thomas , SHAMJI, Alykhan , XAVIER, Ramnik , FISHER, David E. , MUJAHID, Nisma
IPC分类号: C07D487/04 , A61K31/519 , A61P35/00 , A61P7/00 , A61P19/00 , A61P21/00 , A61P25/00 , A61P37/00
摘要: The present disclosure provides compounds of Formula ( I ), ( II ), and ( III ). The provided compounds are able to bind protein kinases ( e . g ., SIK) and may be useful in modulating ( e.g., inhibiting) the activity of a protein kinase ( e.g., SIK, ( e.g., SIK1, SIK2, or SIK3)) in a subject or cell. The provided compounds may be useful in treating or preventing a disease ( e . g ., proliferative disease, musculoskeletal disease, genetic disease, hematological disease, neurological disease, painful condition, psychiatric disorder, or metabolic disorder) in a subject in need thereof. Also provided are pharmaceutical compositions, kits, methods, and uses that include or involve a compound described herein.
-
公开(公告)号:EP4310496A2
公开(公告)日:2024-01-24
申请号:EP23195169.0
申请日:2018-07-12
申请人: Dana-Farber Cancer Institute, Inc. , The General Hospital Corporation d/b/a Massachusetts General Hospital
发明人: GRAY, Nathanael S. , HAGGARTY, Stephen J. , CAI, Quan , TELO BAPTISTA LIMA DA SILVA, Maria Catarina , ZHANG, Tinghu , FERGUSON, Fleur M.
IPC分类号: G01N33/534
摘要: Provided herein are bifunctional compounds that bind tau protein and/or promote targeted ubiquitination for the degradation of tau protein. In particular, provided are compounds that can bind tau protein, a protein whose aggregation is implicated in a variety of neurodegenerative disease (e.g., tauopathies), and can promote its degradation by recruiting an E3 ubiquitin ligase (e.g., Cereblon), which can ubiquitinate tau protein, marking it for proteasomal degradation. Also provided are radiolabeled forms of the bifunctional compounds, pharmaceutical compositions comprising the bifunctional compounds, methods of detecting and/or diagnosing neurological disorders, methods of detecting and/or diagnosing pathological aggregation of tau protein (e.g., in the central nervous system), methods of treating and/or preventing neurological disorders, and methods of promoting the degradation of tau protein by E3 ubiquitin ligase activity in a subject by administering a compound or composition described herein.
-
公开(公告)号:EP4341254A1
公开(公告)日:2024-03-27
申请号:EP22805453.2
申请日:2022-05-19
发明人: GRAY, Nathanael S. , TENG, Mingxing , WANG, Eric , JIANG, Jie , ZHANG, Tinghu , CANTLEY, Lewis C. , FISCHER, Eric S. , DONOVAN, Katherine A.
IPC分类号: C07D403/12 , C07D403/14 , C07D417/14
-
公开(公告)号:EP4225300A1
公开(公告)日:2023-08-16
申请号:EP21878296.9
申请日:2021-10-04
IPC分类号: A61K31/40 , A61K31/4025 , A61K31/519 , C07D207/04 , C07D487/00 , C07D487/04
-
公开(公告)号:EP4058015A1
公开(公告)日:2022-09-21
申请号:EP20888144.1
申请日:2020-11-11
发明人: SCOTT, David A. , HEPPNER, David , GERO, Thomas , CULLIS, Courtney A. , TO, Ciric , HUANG, Shih-Chung , HU, Yongbo , STROUD, Steve , BEYETT, Tyler , ECK, Michael , GRAY, Nathanael S.
IPC分类号: A61K31/395 , A61K31/435 , A61K31/4353 , C07D253/00 , C07D471/02 , C07D471/04
-
公开(公告)号:EP4051386A1
公开(公告)日:2022-09-07
申请号:EP20882103.3
申请日:2020-10-29
发明人: GRAY, Nathanael S. , LIU, Hu , ZHANG, Tinghu , JONES, Lyn Howard , CHE, Jianwei
IPC分类号: A61P35/00 , C07D401/04 , C07D401/14
-
公开(公告)号:EP3828185A3
公开(公告)日:2021-09-01
申请号:EP21152496.2
申请日:2010-01-06
IPC分类号: C07D471/14 , C07D487/04 , C07D487/14 , C07D491/14 , C07D495/14 , C07D498/04 , C07D513/04 , A61P35/00 , A61P29/00 , A61K31/4985 , A61K31/519
摘要: The present invention relates to novel pyrimido-diazepinone compounds, methods of modulating protein kinases, including MPS1 (TTK), ERK5 (BMK1, MAPK7), polo kinase 1,2,3, or 4, Ackl, Ack2, Abl, DCAMKL1, ABL1, Abl mutants, DCAMKL2, ARK5, BRK, MKNK2, FGFR4, TNK1, PLK1, ULK2, PLK4, PRKD1, PRKD2, PRKD3, ROS1, RPS6KA6, TAOK1, TAOK3, TNK2, Bcr-Abl, GAK, cSrc, TPR-Met, Tie2, MET, FGFR3, Aurora, Axl, Bmx, BTK, c-kit, CHK2, Flt3, MST2, p70S6K, PDGFR, PKB, PKC, Raf, ROCK-H, Rskl, SGK, TrkA, TrkB and TrkC, and the use of such compounds in the treatment of various diseases, disorders or conditions.
-
公开(公告)号:EP3866801A1
公开(公告)日:2021-08-25
申请号:EP19873444.4
申请日:2019-10-16
发明人: GRAY, Nathanael S. , HATCHER, John
IPC分类号: A61K31/454
-
-
-
-
-
-
-
-
-